Danaher Shares Drop 10% as Q2 Earnings Beat and Guidance Rise
Updated
Updated · Seeking Alpha · Jul 21
Danaher Shares Drop 10% as Q2 Earnings Beat and Guidance Rise
3 articles · Updated · Seeking Alpha · Jul 21
Summary
Danaher stock fell 10% in premarket trading Tuesday even after the company topped Wall Street’s second-quarter expectations and lifted its full-year earnings outlook.
Adjusted earnings came in at $1.94 a share, with revenue also beating estimates, underscoring the disconnect between the results and the market’s initial reaction.
The move suggests investors were looking past the headline beat and higher guidance, focusing instead on whether Danaher’s life sciences and diagnostics businesses can sustain stronger growth.
The selloff highlights how, in the current earnings season, better-than-expected results alone have not guaranteed support for shares when expectations for future demand remain high.